Diagnosis and Management of Recurrent Phyllodes Tumors

Clinical Presentation and Diagnosis

The National Comprehensive Cancer Network recommends diagnosis of recurrent phyllodes tumors requires clinical examination, imaging with ultrasound and mammography, and tissue sampling with histology preferred over cytology, followed by chest imaging to exclude metastatic disease 1
A locally recurrent breast mass after previous excision is the hallmark of recurrent phyllodes, typically presenting as a rapidly enlarging, usually painless lump in the same breast 2

The National Comprehensive Cancer Network suggests that when a patient presents with suspected recurrence after phyllodes excision, proceed systematically with history and physical examination focusing on the previous surgical site, looking specifically for a palpable mass and documenting growth rate 1
Ultrasound is mandatory as the primary imaging modality, and mammogram should be used to evaluate the entire breast and contralateral side 1
Chest imaging should be considered to screen for distant metastases, particularly in borderline and malignant subtypes 1
Tissue sampling with histology is preferred over fine needle aspiration or core biopsy, as core needle biopsy may not reliably distinguish recurrent phyllodes from other lesions 1

The National Comprehensive Cancer Network recommends re-excision with wide margins (≥1 cm) without axillary staging as the definitive treatment for recurrent phyllodes tumors without metastatic disease 1
Consider postoperative radiation therapy (category 2B) if additional recurrence would create significant morbidity, such as chest wall recurrence after salvage mastectomy, following soft tissue sarcoma principles 1
Radiotherapy should be specifically considered for large tumors (>5 cm), infiltrative margins, or cases where clear margins could not be achieved despite re-excision attempts 3

Borderline and malignant recurrent phyllodes tumors should be referred to specialist sarcoma centers for pathology review and multidisciplinary team discussion to ensure appropriate risk stratification and treatment planning 2